NuCana (NCNA) Net Equity Issued and Repurchased (2018 - 2025)

NuCana (NCNA) reported Net Equity Issued and Repurchased of $25.6 million for Q3 2025, up 303.64% on a YoY basis from $6.3 million in Q3 2024, and up 745.46% sequentially from $3.0 million in Q4 2024.

NuCana (NCNA) Net Equity Issued and Repurchased (2018 - 2025) Analysis & Trends

NuCana (NCNA) has 8 years of Net Equity Issued and Repurchased data on file, last reported at $25.6 million in Q3 2025.

  • For the quarter ending Q3 2025, Net Equity Issued and Repurchased rose 303.64% year-over-year to $25.6 million; the trailing twelve-month figure through Dec 2025 stood at $35.0 million (up 210.47% YoY), and the FY2025 full-year result was $26.6 million, up 138.52% from the prior year.
  • Net Equity Issued and Repurchased improved to $25.6 million in Q3 2025, from $3.0 million in the prior quarter.
  • In the past five years, Net Equity Issued and Repurchased ranged from a high of $25.6 million in Q3 2025 to a low of -$272959.5 in Q3 2021.
  • A 5-year average of $3.1 million and a median of $268355.0 in 2023 frame the typical range for Net Equity Issued and Repurchased.
  • Across the five-year window, Net Equity Issued and Repurchased slumped 100.33% in 2021 and jumped 155606.65% in 2024, its largest moves.
  • Tracing NCNA's Net Equity Issued and Repurchased over 5 years: stood at $266906.1 in 2021, then slumped by 99.5% to $1341.8 in 2022, then surged by 2212.41% to $31028.8 in 2023, then surged by 9653.83% to $3.0 million in 2024, then surged by 745.46% to $25.6 million in 2025.
  • Business Quant data shows NCNA's Net Equity Issued and Repurchased at $25.6 million in Q3 2025, $3.0 million in Q4 2024, and $6.3 million in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 163.10 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 141.90 Mn
10 Alnylam Pharmaceuticals 35.71 Bn 32.70 Bn 959.66 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2025 25.59 Mn
Sep 30, 2025 25.59 Mn
Dec 31, 2024 3.03 Mn
Dec 31, 2024 3.03 Mn
Sep 30, 2024 6.34 Mn
Sep 30, 2024 6.34 Mn
Mar 31, 2024 1.89 Mn
Mar 31, 2024 1.89 Mn
Dec 31, 2023 31,028.80
Dec 31, 2023 31,028.80
Sep 30, 2023 269,803.86
Sep 30, 2023 269,803.86
Jun 30, 2023 12,513.63
Jun 30, 2023 12,513.63
Mar 31, 2023 1,215.51
Mar 31, 2023 1,215.51
Mar 31, 2022 1,341.84
Mar 31, 2022 1,341.84
Dec 31, 2021 266,906.10
Dec 31, 2021 266,906.10